Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo
Connie Kang
Topics & Concepts
MedicineRuxolitinibVitiligoAdverse effectDermatologyClinical trialJanus kinaseInternal medicineMyelofibrosisBone marrowCytokinemelanin and skin pigmentationSkin Protection and AgingMast cells and histamine